In Search of a consensus terminology in the field of platelet concentrates for surgical use: Platelet-Rich Plasma (PRP), Platelet-Rich Fibrin (PRF), fibrin gel polymerization and leukocytes

Current Pharmaceutical Biotechnology

Volumn 13, Issue 7, 2012, Pages 1131-1137

  Dohan Ehrenfest, David M ^a   Bielecki, Tomasz ^b   Mishra, Allan ^c   Borzini, Piero ^d   Inchingolo, Francesco ^e   Sammartino, Gilberto ^f   Rasmusson, Lars ^g   Everts, Peter A ^h  

^a Chonnam National University   (South Korea)

^b MEDICAL UNIVERSITY OF SILESIA   (Poland)

^c STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^d Transfusion Medicine and Regeneration Medicine ^*  (Italy)

^e UNIVERSITY OF BARI   (Italy)

^f UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^g UNIVERSITY OF GOTHENBURG   (Sweden)

^h CATHARINA HOSPITAL   (Netherlands)

Author keywords

Fibrin; Leukocyte; Platelet; Platelet rich fibrin (PRF); Platelet rich plasma (PRP)

Indexed keywords

ANTICOAGULANT AGENT; BIOMATERIAL; BLOOD CLOTTING FACTOR 5; CATECHOLAMINE; FIBRIN; FIBRINOGEN; GELATIN; GROWTH FACTOR; OSTEONECTIN; SEROTONIN; THROMBOCYTE CONCENTRATE; VON WILLEBRAND FACTOR; WOUND HEALING PROMOTING AGENT;

ARTICLE; BLOOD CLOTTING; CENTRIFUGATION; GEL; HEALING; HUMAN; LEUKOCYTE; MAXILLOFACIAL SURGERY; NOMENCLATURE; ORAL SURGERY; POLYMERIZATION; SURGICAL SCIENCE; THROMBOCYTE RICH PLASMA; WOUND HEALING;

EID: 84861165899     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/138920112800624328     Document Type: Article

References (68)

1. Matras, H. Die Wirkungen vershiedener Fibrinpraparate auf Kontinuitat-strennungen der Rattenhaut. Osterr. Z. Stomatol., 1970, 67(9), 338-359.
2. Gibble, J.W.; Ness, P.M. Fibrin glue: the perfect operative sealant? Transfusion, 1990, 30(8), 741-747.
3. Dohan, D.M.; Choukroun, J.; Diss, A.; Dohan, S.L.; Dohan, A.J.; Mouhyi, J.; Gogly, B. Platelet-rich fibrin (PRF): a secondgeneration platelet concentrate. Part I: technological concepts and evolution. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod., 2006, 101(3), e37-44.
4. Dohan Ehrenfest, D.M.; Rasmusson, L.; Albrektsson, T. Classification of platelet concentrates: from pure platelet-rich plasma (PPRP) to leucocyte-and platelet-rich fibrin (L-PRF). Trends Biotechnol., 2009, 27(3), 158-167.
5. Mosesson, M.W.; Siebenlist, K.R.; Meh, D.A. The structure and biological features of fibrinogen and fibrin. Ann. N.Y. Acad. Sci., 2001, 936, 11-30.
6. Man, D.; Plosker, H.; Winland-Brown, J.E. The use of autologous platelet-rich plasma (platelet gel) and autologous platelet-poor plasma (fibrin glue) in cosmetic surgery. Plast. Reconstr. Surg., 2001, 107(1), 229-237; discussion 238-229.
7. Clark, R.A. Fibrin and wound healing. Ann. N.Y. Acad. Sci., 2001, 936(355-367.
8. van Hinsbergh, V.W.; Collen, A.; Koolwijk, P. Role of fibrin matrix in angiogenesis. Ann. N.Y. Acad. Sci., 2001, 936, 426-437.
9. Everts, P.A.; Hoffmann, J.; Weibrich, G.; Mahoney, C.B.; Schonberger, J.P.; van Zundert, A.; Knape, J.T. Differences in platelet growth factor release and leucocyte kinetics during autologous platelet gel formation. Transfus. Med., 2006, 16(5), 363-368.
10. Marx, R.E.; Carlson, E.R.; Eichstaedt, R.M.; Schimmele, S.R.; Strauss, J.E.; Georgeff, K.R. Platelet-rich plasma: Growth factor enhancement for bone grafts. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod., 1998, 85(6), 638-646.
11. Kingsley, C.S. Blood coagulation; evidence of an antagonist to factor VI in platelet-rich human plasma. Nature, 1954, 173(4407), 723-724.
12. Rosenthal, A.R.; Harbury, C.; Egbert, P.R.; Rubenstein, E. Use of a platelet-fibrinogen-thrombin mixture as a corneal adhesive: experiments with sutureless lamellar keratoplasty in the rabbit. Invest. Ophthalmol., 1975, 14(11), 872-875.
13. Rosenthal, A.R.; Egbert, P.R.; Harbury, C.; Hopkins, J.L.; Rubenstein, E. Use of platelet-fibrinogen-thrombin mixture to seal experimental penetrating corneal wounds. Albrecht Von Graefes Arch. Klin. Exp. Ophthalmol., 1978, 207(2), 111-115.
14. Pearl, R.M.; Wustrack, K.O.; Harbury, C.; Rubenstein, E.; Kaplan, E.N. Microvascular anastomosis using a blood product sealantadhesive. Surg. Gynecol. Obstet., 1977, 144(2), 227-231.
15. Silverberg, G.D.; Harbury, C.B.; Rubenstein, E. A physiological sealant for cerebrospinal fluid leaks. J. Neurosurg., 1977, 46(2), 215-219.
16. Fischer, H. A method of suture-free anastomosis of nerve transplantation is being reported, using facial nerve as the example (author's transl). Laryngol. Rhinol. Otol. (Stuttg.), 1979, 58(2), 154-156.
17. Knighton, D.R.; Ciresi, K.F.; Fiegel, V.D.; Austin, L.L.; Butler, E.L. Classification and treatment of chronic nonhealing wounds. Successful treatment with autologous platelet-derived wound healing factors (PDWHF). Ann. Surg., 1986, 204(3), 322-330.
18. Knighton, D.R.; Doucette, M.; Fiegel, V.D.; Ciresi, K.; Butler, E.; Austin, L. The use of platelet derived wound healing formula in human clinical trials. Prog. Clin. Biol. Res., 1988, 266, 319-329.
19. Knighton, D.R.; Ciresi, K.; Fiegel, V.D.; Schumerth, S.; Butler, E.; Cerra, F. Stimulation of repair in chronic, nonhealing, cutaneous ulcers using platelet-derived wound healing formula. Surg. Gynecol. Obstet., 1990, 170(1), 56-60.
20. Whitman, D.H.; Berry, R.L.; Green, D.M. Platelet gel: an autologous alternative to fibrin glue with applications in oral and maxillofacial surgery. J. Oral Maxillofac. Surg., 1997, 55(11), 1294-1299.
21. Gassling, V.L.; Acil, Y.; Springer, I.N.; Hubert, N.; Wiltfang, J. Platelet-rich plasma and platelet-rich fibrin in human cell culture. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod., 2009, 108(1), 48-55.
22. Dohan Ehrenfest, D.M.; Del Corso, M.; Inchingolo, F.; Sammartino, G.; Charrier, J.B. Platelet-Rich Plasma (PRP) and Platelet-Rich Fibrin (PRF) in human cell cultures: growth factor release and contradictory results. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod., 2010, 110(4), 418-421.
23. He, L.; Lin, Y.; Hu, X.; Zhang, Y.; Wu, H. A comparative study of platelet-rich fibrin (PRF) and platelet-rich plasma (PRP) on the effect of proliferation and differentiation of rat osteoblasts in vitro. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod., 2009, 108(5), 707-713.
24. Dohan Ehrenfest, D.M.; Del Corso, M.; Inchingolo, F.; Charrier, J.B. Selecting a relevant in vitro cell model for testing and comparing the effects of a Choukroun's Platelet-Rich Fibrin (PRF) membrane and a Platelet-Rich Plasma (PRP) gel: tricks and traps. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod., 2010, 110(4), 409-411.
25. Dohan Ehrenfest, D.M.; de Peppo, G.M.; Doglioli, P.; Sammartino, G. Slow release of growth factors and thrombospondin-1 in Choukroun's platelet-rich fibrin (PRF): a gold standard to achieve for all surgical platelet concentrates technologies. Growth Factors, 2009, 27(1), 63-69.
26. Mazzucco, L.; Balbo, V.; Cattana, E.; Guaschino, R.; Borzini, P. Not every PRP-gel is born equal. Evaluation of growth factor availability for tissues through four PRP-gel preparations: Fibrinet, RegenPRP-Kit, Plateltex and one manual procedure. Vox Sang., 2009, 97(2), 110-118.
27. Dohan Ehrenfest, D.M.; Diss, A.; Odin, G.; Doglioli, P.; Hippolyte, M.P.; Charrier, J.B. In vitro effects of Choukroun's PRF (plateletrich fibrin) on human gingival fibroblasts, dermal prekeratinocytes, preadipocytes, and maxillofacial osteoblasts in primary cultures. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod., 2009, 108(3), 341-352.
28. Dohan Ehrenfest, D.M.; Doglioli, P.; de Peppo, G.M.; Del Corso, M.; Charrier, J.B. Choukroun's platelet-rich fibrin (PRF) stimulates in vitro proliferation and differentiation of human oral bone mesenchymal stem cell in a dose-dependent way. Arch. Oral Biol., 2010, 55(3), 185-194.
29. Anitua, E. Plasma rich in growth factors: preliminary results of use in the preparation of future sites for implants. Int. J. Oral Maxillofac. Implants, 1999, 14(4), 529-535.
30. Anitua, E.; Sanchez, M.; Orive, G.; Andia, I. The potential impact of the preparation rich in growth factors (PRGF) in different medical fields. Biomaterials, 2007, 28(31), 4551-4560.
31. Weibrich, G.; Kleis, W.K.; Hitzler, W.E.; Hafner, G. Comparison of the platelet concentrate collection system with the plasma-richin-growth-factors kit to produce platelet-rich plasma: a technical report. Int. J. Oral Maxillofac. Implants, 2005, 20(1), 118-123.
32. Dohan Ehrenfest, D.M.; Bielecki, T.; Del Corso, M.; Inchingolo, F.; Sammartino, G. Shedding light in the controversial terminology for platelet-rich products: Platelet-Rich Plasma (PRP), Platelet-Rich Fibrin (PRF), Platelet-Leukocyte Gel (PLG), Preparation Rich in Growth Factors (PRGF), classification and commercialism. J. Biomed. Mater. Res. A, 2010, 95(4), 1280-1282.
33. Choukroun, J.; Adda, F.; Schoeffler, C.; Vervelle, A. Une opportunité en paro-implantologie: le PRF. Implantodontie, 2001, 42, 55-62.
34. Sunitha Raja, V.; Munirathnam Naidu, E. Platelet-rich fibrin: evolution of a second-generation platelet concentrate. Indian J. Dent. Res., 2008, 19(1), 42-46.
35. Dohan, D.M.; Choukroun, J.; Diss, A.; Dohan, S.L.; Dohan, A.J.; Mouhyi, J.; Gogly, B. Platelet-rich fibrin (PRF): a secondgeneration platelet concentrate. Part II: platelet-related biologic features. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod., 2006, 101(3), e45-50.
36. Dohan, D.M.; Choukroun, J.; Diss, A.; Dohan, S.L.; Dohan, A.J.; Mouhyi, J.; Gogly, B. Platelet-rich fibrin (PRF): a secondgeneration platelet concentrate. Part III: leucocyte activation: a new feature for platelet concentrates? Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod., 2006, 101(3), e51-55.
37. Choukroun, J.; Diss, A.; Simonpieri, A.; Girard, M.O.; Schoeffler, C.; Dohan, S.L.; Dohan, A.J.; Mouhyi, J.; Dohan, D.M. Plateletrich fibrin (PRF): a second-generation platelet concentrate. Part IV: clinical effects on tissue healing. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod., 2006, 101(3), e56-60.
38. Choukroun, J.; Diss, A.; Simonpieri, A.; Girard, M.O.; Schoeffler, C.; Dohan, S.L.; Dohan, A.J.; Mouhyi, J.; Dohan, D.M. Plateletrich fibrin (PRF): a second-generation platelet concentrate. Part V: histologic evaluations of PRF effects on bone allograft maturation in sinus lift. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod., 2006, 101(3), 299-303.
39. Mazor, Z.; Horowitz, R.A.; Del Corso, M.; Prasad, H.S.; Rohrer, M.D.; Dohan Ehrenfest, D.M. Sinus floor augmentation with simultaneous implant placement using Choukroun's platelet-rich fibrin as the sole grafting material: a radiologic and histologic study at 6 months. J. Periodontol., 2009, 80(12), 2056-2064.
40. Del Corso, M.; Sammartino, G.; Dohan Ehrenfest, D.M. Re: "Clinical evaluation of a modified coronally advanced flap alone or in combination with a platelet-rich fibrin membrane for the treatment of adjacent multiple gingival recessions: a 6-month study". J. Periodontol., 2009, 80(11), 1694-1697; author reply 1697-1699.
41. Dohan Ehrenfest, D.M.; Lemo, N.; Jimbo, R.; Sammartino, G. Selecting a relevant animal model for testing the in vivo effects of Choukroun's Platelet-Rich Fibrin (PRF): rabbit tricks and traps. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod., 2010, 110(4), 413-416.
42. Simonpieri, A.; Choukroun, J.; Del Corso, M.; Sammartino, G.; Dohan Ehrenfest, D.M. Simultaneous sinus-lift and implantation using microthreaded implants and leukocyte-and platelet-rich fibrin as sole grafting material: a six-year experience. Implant Dent., 2011, 20(1), 2-12.
43. Dohan Ehrenfest, D.M.; Del Corso, M.; Diss, A.; Mouhyi, J.; Charrier, J.B. Three-Dimensional Architecture and Cell Composition of a Choukroun's Platelet-Rich Fibrin Clot and Membrane. J. Periodontol., 2010, 81(4), 546-555.
44. Dohan Ehrenfest, D.M. How to optimize the preparation of Leukocyte-and Platelet-Rich Fibrin (L-PRF, Choukroun's technique) clots and membranes: introducing the PRF Box. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod., 2010, 110(3), 275-278.
45. Bielecki, T.; Gazdzik, T.S.; Szczepanski, T. Re: "The effects of local platelet rich plasma delivery on diabetic fracture healing". What do we use: Platelet-rich plasma or platelet-rich gel? Bone, 2006, 39(6), 1388; author reply 1389.
46. Mishra, A.; Pavelko, T. Treatment of chronic elbow tendinosis with buffered platelet-rich plasma. Am. J. Sports Med., 2006, 34(11), 1774-1778.
47. Everts, P.A.; van Zundert, A.; Schonberger, J.P.; Devilee, R.J.; Knape, J.T. What do we use: platelet-rich plasma or plateletleukocyte gel? J. Biomed. Mater. Res. A, 2008, 85(4), 1135-1136.
48. Bielecki, T.; Gazdzik, T.S.; Szczepanski, T. Benefit of percutaneous injection of autologous platelet-leukocyte-rich gel in patients with delayed union and nonunion. Eur. Surg. Res., 2008, 40(3), 289-296.
49. Bielecki, T.M.; Gazdzik, T.S.; Arendt, J.; Szczepanski, T.; Krol, W.; Wielkoszynski, T. Antibacterial effect of autologous platelet gel enriched with growth factors and other active substances: an in vitro study. J. Bone Joint Surg. Br., 2007, 89(3), 417-420.
50. Cieslik-Bielecka, A.; Bielecki, T.; Gazdzik, T.S.; Arendt, J.; Krol, W.; Szczepanski, T. Autologous platelets and leukocytes can improve healing of infected high-energy soft tissue injury. Transfus. Apher. Sci., 2009, 41(1), 9-12.
51. Cieslik-Bielecka, A.; Bielecki, T.; Gazdzik, T.S.; Cieslik, T.; Szczepanski, T. Improved treatment of mandibular odontogenic cysts with platelet-rich gel. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod., 2008, 105(4), 423-429.
52. Cieslik-Bielecka, A.; Gazdzik, T.S.; Bielecki, T.M.; Cieslik, T. Why the platelet-rich gel has antimicrobial activity? Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod., 2007, 103(3), 303-305; author reply 305-306.
53. Wrotniak, M.; Bielecki, T.; Gazdzik, T.S. Current opinion about using the platelet-rich gel in orthopaedics and trauma surgery. Ortop. Traumatol. Rehabil., 2007, 9(3), 227-238.
54. Everts, P.A.; Devilee, R.J.; Brown Mahoney, C.; van Erp, A.; Oosterbos, C.J.; Stellenboom, M.; Knape, J.T.; van Zundert, A. Exogenous application of platelet-leukocyte gel during open subacromial decompression contributes to improved patient outcome. A prospective randomized double-blind study. Eur. Surg. Res., 2008, 40(2), 203-210.
55. Everts, P.A.; Jakimowicz, J.J.; van Beek, M.; Schonberger, J.P.; Devilee, R.J.; Overdevest, E.P.; Knape, J.T.; van Zundert, A. Reviewing the structural features of autologous platelet-leukocyte gel and suggestions for use in surgery. Eur. Surg. Res., 2007, 39(4), 199-207.
56. Everts, P.A.; Overdevest, E.P.; Jakimowicz, J.J.; Oosterbos, C.J.; Schonberger, J.P.; Knape, J.T.; van Zundert, A. The use of autologous platelet-leukocyte gels to enhance the healing process in surgery, a review. Surg. Endosc., 2007, 21(11), 2063-2068.
57. Moojen, D.J.; Everts, P.A.; Schure, R.M.; Overdevest, E.P.; van Zundert, A.; Knape, J.T.; Castelein, R.M.; Creemers, L.B.; Dhert, W.J. Antimicrobial activity of platelet-leukocyte gel against Staphylococcus aureus. J. Orthop. Res., 2008, 26(3), 404-410.
58. Fernandez-Barbero, J.E.; Galindo-Moreno, P.; Avila-Ortiz, G.; Caba, O.; Sanchez-Fernandez, E.; Wang, H.L. Flow cytometric and morphological characterization of platelet-rich plasma gel. Clin. Oral Implants Res., 2006, 17(6), 687-693.
59. Dohan Ehrenfest, D.M.; Coelho, P.G.; Kang, B.S.; Sul, Y.T.; Albrektsson, T. Classification of osseointegrated implant surfaces: materials, chemistry and topography. Trends Biotechnol., 2010, 28(4), 198-206.
60. Weibrich, G.; Kleis, W.K. Curasan PRP kit vs. PCCS PRP system. Collection efficiency and platelet counts of two different methods for the preparation of platelet-rich plasma. Clin. Oral Implants Res., 2002, 13(4), 437-443.
61. Weibrich, G.; Kleis, W.K.; Buch, R.; Hitzler, W.E.; Hafner, G. The Harvest Smart PRePTM system versus the Friadent-Schutze platelet-rich plasma kit. Clin. Oral Implants Res., 2003, 14(2), 233-239.
62. Choi, B.H.; Zhu, S.J.; Kim, B.Y.; Huh, J.Y.; Lee, S.H.; Jung, J.H. Effect of platelet-rich plasma (PRP) concentration on the viability and proliferation of alveolar bone cells: an in vitro study. Int. J. Oral Maxillofac. Surg., 2005, 34(4), 420-424.
63. Graziani, F.; Ivanovski, S.; Cei, S.; Ducci, F.; Tonetti, M.; Gabriele, M. The in vitro effect of different PRP concentrations on osteoblasts and fibroblasts. Clin. Oral Implants Res., 2006, 17(2), 212-219.
64. Uggeri, J.; Belletti, S.; Guizzardi, S.; Poli, T.; Cantarelli, S.; Scandroglio, R.; Gatti, R. Dose-dependent effects of platelet gel releasate on activities of human osteoblasts. J. Periodontol., 2007, 78(10), 1985-1991.
65. Weibrich, G.; Hansen, T.; Kleis, W.; Buch, R.; Hitzler, W.E. Effect of platelet concentration in platelet-rich plasma on peri-implant bone regeneration. Bone, 2004, 34(4), 665-671.
66. Mishra, A.; Collado, H.; Fredericson, M. Platelet-rich plasma compared with corticosteroid injection for chronic lateral elbow tendinosis. P.M. R., 2009, 1(4), 366-370.
67. Mishra, A.; Woodall, J. Jr.; Vieira, A. Treatment of tendon and muscle using platelet-rich plasma. Clin. Sports Med., 2009, 28(1), 113-125.
68. Woodall, J., Jr.; Tucci, M.; Mishra, A.; Benghuzzi, H. Cellular effects of platelet rich plasma: a study on HL-60 macrophage-like cells. Biomed. Sci. Instrum., 2007, 43, 266-271.